Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes

Table 1

Characteristics of the study subjects.

Variables	1,5-Anhydroglucitol (μg/mL)				for trend
	<1.2	1.2-2.0	2.1-4.4	≥4.5
No. of patients	150	159	156	158
Age (years)					<0.001
Men, (%)	110 (73.3)	126 (79.2)	109 (69.9)	92 (58.2)	0.001
Duration of diabetes (years)					0.001
BMI (kg/m^2)					0.374
SBP (mmHg)					0.507
DBP (mmHg)					0.445
CRP (mg/dL)					0.023
TG (mmol/L)					<0.001
TC (mmol/L)					<0.001
LDL-c (mmol/L)					0.001
HDL-c (mmol/L)					0.005
eGFR (mL/min/1.73 m^2)					0.001
FPG (mmol/L)					<0.001
2hPG (mmol/L)					<0.001
HbA1c (%)					<0.001
GA (%)					<0.001
ARCP (ng/mL)					<0.001
Glucose-lowering drugs, (%)
Insulin	150 (100.0)	157 (98.7)	141 (90.4)	104 (65.8)	<0.001
Metformin	49 (32.7)	57 (35.8)	59 (37.8)	79 (50.0)	0.001
TZDs	0 (0.00)	0 (0.00)	4 (2.6)	9 (5.7)	0.001
α-Glucosidase inhibitors	18 (12.0)	20 (12.6)	32 (20.5)	35 (22.2)	0.002